Reduction of revascularization with icosapent ethyl in patients with hypertriglyceridemia - PACE-CME

Reduction of revascularization with icosapent ethyl in patients with hypertriglyceridemia

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

New ESC Guidelines for CCS and PAAD
New ESC Guidelines for CCS and PAAD
ESC Congress 2024
New ESC Guidelines for CCS and PAAD
- Pierre Sabouret, MD, PhD
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
ESC Congress 2024
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
- C. David Mazer, MD
Lp(a) in patients with recent CHD
Lp(a) in patients with recent CHD
ESC Congress 2024
Lp(a) in patients with recent CHD
- Prof. Kausik Ray, MBChB, MD, MPhil
Predicting 30-year CV outcomes in women
Predicting 30-year CV outcomes in women
ESC Congress 2024
Predicting 30-year CV outcomes in women
- Paul Ridker, MD